We found 124 records for "Legal"

Articles

Protecting the future: the regenerative medicine evolution

10th March 2015

 Protecting the future: the regenerative medicine evolutionArticles

Regenerative medicine has left the realms of sci-fi to become a practical, new form of technology, which can give patients amazing results with serious, previously untreatable injuries. However, the legalities...

Read more

We need to talk about ChemSex: risks of Hep C and HIV are high

2nd March 2015

 We need to talk about ChemSex: risks of Hep C and HIV are highArticles

More gay men in the UK are presenting to clinicians with complicated issues associated with drug use and consent to sex in ChemSex environments (taking recreational drugs during sex and...

Read more

Modern market research methods and moral dilemmas

17th February 2015

 Modern market research methods and moral dilemmasArticles

This is the first in a series of three articles examining the legal and ethical dilemmas faced when using new mediums and data sources for healthcare market research and data...

Read more

Putting the case for regenerative medicine

11th December 2014

 Putting the case for regenerative medicine Articles

Stem cell research always courts controversy and an application by the International Stem Cell Corporation (ISCC) for two UK patents for the creation of synthetic cornea from retinal stem cells...

Read more

News

Amgen fails to block Neupogen biosimilar

20th March 2015

 Amgen fails to block Neupogen biosimilarNews

Amgen has failed in a legal attempt to block the sale of a biosimilar version of its white blood cell stimulator Neupogen developed by Novartis' Sandoz subsidiary.The biosimilar – called...

Read more

Tough times ahead in US market for Glaxo and AZ

17th February 2015

 Tough times ahead in US market for Glaxo and AZNews

GlaxoSmithKline has replaced the head of its North American business unit as it struggles to maintain sales in its biggest market.Meanwhile, AstraZeneca has also been dealt a major blow to its...

Read more

US doctor faces jail in pharma bribery case

16th February 2015

 US doctor faces jail in pharma bribery caseNews

A US doctor is facing a jail sentence after pleading guilty to over-prescribing a hazardous anti-psychotic drug to patients in return for kickbacks.71-year-old Michael Reinstein from Chicago admitted to accepting...

Read more

Medical group challenges Sovaldi's EU patent

10th February 2015

 Medical group challenges Sovaldi's EU patentNews

A medical organisation is trying to overturn Gilead Sciences' European patent for hepatitis C drug Sovaldi so cut-price generics can be made available.The Paris-based Médecins du Monde (MDM) group has...

Read more

Events

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

30th March 2015 - 31st March 2015

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

*The first in-house/corporate counsel attend for free* Join your in-house peers at the Post-Grant Patent Challenges at the PTAB on March 30-31 at San Jose City Hall, the future home...

Read more

Viral Safety & Raw Materials Congress

24th June 2015 - 25th June 2015

Viral Safety & Raw Materials Congress

Join us at this year’s Viral Safety and Raw Materials Congress taking place in Vienna on the 24th-25th June to network and exchange with leading industry representatives, regulatory bodies and...

Read more

Orphan Drugs Summit

17th September 2015 - 18th September 2015

Orphan Drugs Summit

Changing times ask for solid relationships. Times are changing. A renewed interest from big pharma in the rare disease landscape has awakened due to large-scale patent expirations, competition from generics &...

Read more